133 related articles for article (PubMed ID: 3518522)
21. Immunohistological reactivity pattern of the anti-cutaneous T-cell lymphoma antibody BE2.
Ralfkiaer E; Gatter KC; Wantzin GL; Thomsen K; Mason DY
Br J Dermatol; 1986 Jun; 114(6):677-84. PubMed ID: 3521711
[TBL] [Abstract][Full Text] [Related]
22. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement.
Ritter JH; Wick MR; Adesokan PN; Fitzgibbon JF; Zhu X; Humphrey PA
Am J Clin Pathol; 1997 Jul; 108(1):60-8. PubMed ID: 9208979
[TBL] [Abstract][Full Text] [Related]
23. Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation.
Wood GS; Strickler JG; Deneau DG; Egbert B; Warnke RA
J Am Acad Dermatol; 1986 Sep; 15(3):444-58. PubMed ID: 3489740
[TBL] [Abstract][Full Text] [Related]
24. Keratinocyte expression of OKM5 antigen in inflammatory cutaneous disease.
Barker JN; Markey AC; Allen MH; MacDonald DM
Br J Dermatol; 1989 May; 120(5):613-8. PubMed ID: 2474314
[TBL] [Abstract][Full Text] [Related]
25. Use of monoclonal antibodies (UCHL1, Ki-B3) against T and B cell antigens in routine paraffin-embedded skin biopsy specimens.
Sterry W; Hauschild A
J Am Acad Dermatol; 1989 Jul; 21(1):98-107. PubMed ID: 2473100
[TBL] [Abstract][Full Text] [Related]
26. Immunoperoxidase staining of cytoplasmic immunoglobulins. A diagnostic aid in distinguishing cutaneous reactive lymphoid hyperplasia from malignant lymphoma.
Barr RJ; Sun NC; King DF
J Am Acad Dermatol; 1980 Jul; 3(1):58-62. PubMed ID: 6156961
[TBL] [Abstract][Full Text] [Related]
27. Large cell lymphocytoma: follow-up, immunopathology studies, and comparison to cutaneous follicular and Crosti lymphoma.
Winkelmann RK; Dabski K
Arch Dermatol Res; 1987; 279 Suppl():S81-7. PubMed ID: 3310923
[TBL] [Abstract][Full Text] [Related]
28. Lymphomatoid papulosis. Characterization of skin infiltrates by monoclonal antibodies.
Ralfkiaer E; Stein H; Wantzin GL; Thomsen K; Ralfkiaer N; Mason DY
Am J Clin Pathol; 1985 Nov; 84(5):587-93. PubMed ID: 3904400
[TBL] [Abstract][Full Text] [Related]
29. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibody patterns in cutaneous lymphoid infiltrates. Their possible relevance to the diagnosis and categorization of cutaneous lymphomas.
McMillan EM
Dermatol Clin; 1985 Oct; 3(4):593-603. PubMed ID: 2947768
[TBL] [Abstract][Full Text] [Related]
31. The development of a Ki-1-positive large cell non-Hodgkin's lymphoma in pagetoid reticulosis.
Ralfkiaer E; Thomsen K; Agdal N; Hou-Jensen K; Wantzin GL
Acta Derm Venereol; 1989; 69(3):206-11. PubMed ID: 2566223
[TBL] [Abstract][Full Text] [Related]
32. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.
Wagner SN; Wagner C; Reinhold U; Funk R; Zöller M; Goos M
J Invest Dermatol; 1998 Sep; 111(3):464-71. PubMed ID: 9740242
[TBL] [Abstract][Full Text] [Related]
33. [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].
Huber H; Thaler J; Greil R; Gattringer C; Radaszkiewicz T
Onkologie; 1986 Apr; 9(2):108-13. PubMed ID: 3520418
[TBL] [Abstract][Full Text] [Related]
34. In-situ T lymphocyte identification in cutaneous tissue sections of benign and malignant dermatoses.
Chu AC; Fergin PE; MacDonald DM
Histopathology; 1982 Jan; 6(1):25-33. PubMed ID: 7035324
[TBL] [Abstract][Full Text] [Related]
35. Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE.
Brady SP; Magro CM; Diaz-Cano SJ; Wolfe HJ
Hum Pathol; 1999 Feb; 30(2):130-6. PubMed ID: 10029439
[TBL] [Abstract][Full Text] [Related]
36. Expression of proliferating cell nuclear antigen in cutaneous malignant lymphomas and lymphoid infiltrates.
Qiu BS; Luo JM
Chin Med J (Engl); 1994 Jul; 107(7):496-9. PubMed ID: 7956495
[TBL] [Abstract][Full Text] [Related]
37. Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas.
Ralfkiaer E; Hou-Jensen K; Gatter KC; Drzewiecki KT; Mason DY
Virchows Arch A Pathol Anat Histopathol; 1987; 410(4):355-61. PubMed ID: 3101284
[TBL] [Abstract][Full Text] [Related]
38. Combined proliferating cell nuclear antigen and morphometric analysis in the diagnosis of cutaneous lymphoid infiltrates.
Clarke AM; Reid WA; Jack AS
J Clin Pathol; 1993 Feb; 46(2):129-34. PubMed ID: 8096225
[TBL] [Abstract][Full Text] [Related]
39. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients.
Beljaards RC; Meijer CJ; Scheffer E; Toonstra J; van Vloten WA; van der Putte SC; Geerts ML; Willemze R
Am J Pathol; 1989 Dec; 135(6):1169-78. PubMed ID: 2556926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
